NovaBay Pharmaceuticals Inc. (NBY) Quarterly Performance is 42.38%: Here is the Surprise Factor

For the readers interested in the stock health of NovaBay Pharmaceuticals Inc. (NBY). It is currently valued at $1.20. When the transactions were called off in the previous session, Stock hit the highs of $1.17, after setting-off with the price of $1.09. Company’s stock value dipped to $1.07 during the trading on the day. When the trading was stopped its value was $1.15.

Recently in News on May 14, 2020, NovaBay Pharmaceuticals Issues Letter to Stockholders. NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that CEO Justin Hall has issued the following letter to stockholders:. You can read further details here

NovaBay Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.8500 on 04/20/20, with the lowest value was $0.2400 for the same time period, recorded on 03/16/20.

NovaBay Pharmaceuticals Inc. (NBY) full year performance was -29.37%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, NovaBay Pharmaceuticals Inc. shares are logging -35.14% during the 52-week period from high price, and 400.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.24 and $1.85.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3844045 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the NovaBay Pharmaceuticals Inc. (NBY) recorded performance in the market was 79.69%, having the revenues showcasing 42.38% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 40.47M, as it employees total of 28 workers.

The Analysts eye on NovaBay Pharmaceuticals Inc. (NBY)

During the last month, 0 analysts gave the NovaBay Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.8273, with a change in the price was noted +0.6909. In a similar fashion, NovaBay Pharmaceuticals Inc. posted a movement of +137.82% for the period of last 100 days, recording 4,146,992 in trading volumes.

Technical rundown of NovaBay Pharmaceuticals Inc. (NBY)

Raw Stochastic average of NovaBay Pharmaceuticals Inc. in the period of last 50 days is set at 73.50%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 73.50%. In the last 20 days, the company’s Stochastic %K was 66.17% and its Stochastic %D was recorded 59.88%.

Considering, the past performance of NovaBay Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 79.69%. Additionally, trading for the stock in the period of the last six months notably improved by 82.25%, alongside a downfall of -29.37% for the period of the last 12 months. The shares increased approximately by -0.86% in the 7-day charts and went down by 36.26% in the period of the last 30 days. Common stock shares were driven by 42.38% during last recorded quarter.